FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC 3

3 · Milestone Pharmaceuticals Inc. · Filed May 8, 2019

Insider Transaction Report

Form 3
Period: 2019-05-08
Holdings
  • Series A-2 Preferred

    Common Shares (798,974 underlying)
  • Series D-1 Preferred

    Common Shares (306,092 underlying)
  • Common Shares

    30,567
  • Series B Preferred

    Common Shares (574,292 underlying)
  • Series C Preferred

    Common Shares (437,203 underlying)
  • Series A-1 Preferred

    Common Shares (139,849 underlying)
Footnotes (1)
  • [F1]Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and will convert into Common Shares upon the closing of the Issuer's initial public offering.

Documents

1 file
  • 3
    es1900644_3-fonds.xmlPrimary

    OWNERSHIP DOCUMENT